Weimann E, Brack C
Children's Hospital, University of Frankfurt/Main, Germany.
Horm Res. 1996;45(6):261-3. doi: 10.1159/000184801.
High-dose estradiol therapy for reduction of final height may be complicated by severe side effects such as deep vein thrombosis. We report a 14.6-year-old girl with tall stature. In order to reduce final height she was treated with ethinylestradiol and medroxyprogesterone. After arthroscopy she suffered acute deep venous thrombosis of her left leg. Despite being monitored at short intervals, coagulation parameters such as AT III and protein C indicated no development of thrombosis. Medical height reduction with estrogen should be accompanied by heparinisation during longer-lasting periods of immobilisation.
大剂量雌二醇治疗以降低最终身高可能会因严重副作用(如深静脉血栓形成)而变得复杂。我们报告一名14.6岁身材高大的女孩。为了降低最终身高,她接受了炔雌醇和甲羟孕酮治疗。关节镜检查后,她左腿发生急性深静脉血栓形成。尽管进行了短时间间隔监测,但抗凝血酶III和蛋白C等凝血参数显示没有血栓形成。在使用雌激素进行医学性身高降低时,在较长时间固定期间应同时进行肝素化。